ARCHIVES

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

ODAC To Review Taxol Nov. 16; NCI, Bristol to Discuss Pricing

October 23, 1992

IL-2 Trials Proliferate; Biotherapeutics Sees NCI Proposal As Vindication Of Its Policies

May 8, 1987

HHS Hearings to Form National Breast Cancer Strategy. Shalala Says

October 29, 1993

In Brief: Obey Was Right- Tests On 70 Chemical Would Have Been Aborted Under NCI Budget

July 20, 1979

Epstein Hits NCI On Doll, Peto Reports, Greenwald Responds

July 3, 1992

Construction, Pay Raise, Foundation Bills Clear Senate Committee

December 1, 1989